Avid Bioservices Inc (CDMO)

[geocappy1]

I don't think you understand my point. Even if bavituximab ultimately helps the PD-1 drugs, the FDA will require phase 1, 2 and 3 data. It's 5-10 years away minimum.

Here's a fact:

If Opdivo beats docetaxel alone by a lot, a 100% mos improvement successful PPHM SUNRISE trial will be at risk for not receiving approval due to the use of a no longer valid control arm JUST LIKE COTARA WAS BACK IN THE DAY!

I think you are missing a key point. Even if Opdivo improves efficacy by 100% (which I doubt) and bavi improves it 70%, there will still be a need for Bavi because Opdivo is only going to work on a small percentage of people. Small number of responders.

Also, if you combine it with anything but bavi it is going to kill even more people. If it wasn't for the corruption in pharma world and the FDA, many of these drugs would not see the light of day.

My guess is Opdivo needed most of the 582 patients to make it work on a small percentage. More voodoo